药品分类补偿的他国及地区经验被引量：7

Experiences on Reimbursement of Classified Drugs in other Countries and Areas

导出

摘要目的 :为控制我国城镇职工医疗保险药品报销费用提供参考。方法 :参阅文献综述世界上一些国家和地区药品分类补偿的举措 ,从中总结可供借鉴的经验。结果与结论 :根据药品性质分类 ,采用不同支付比例是国际上通行的做法 ;大部分国家及地区不将非处方药品列入药品报销目录范围 ;药品分类给付的目的是增加个人自付的比例 ,减少当局在社会医疗保险经费上的负担 ;控制药品费用必须从控制价格、补偿比例和药品用量3个方面同时着手才能奏效 ;制订药品参考价格和增设处方费等改革措施时要注意利弊分析。 OBJECTIVE:To provide references for the controlling of reimbursement of medicare drug expenditure in urban employees in China.METHODS:Referenced experiences were summed up from classified drug reimbursement acts in other countries and areas stated in the literature review.RESULTS&CONCLUSION:It is a common international policy to clasˉsify drugs by quality and adopt different reimbursement ratio;most of the countries and areas would exclude the reimburseˉments of over-the-counter drugs;the purpose of classified drug payment and reimbursement was to increase the users'payment thereby to lessen the burden of the authorities on the expenditure of social medicare drugs;concerning the controlling of drug expenditure,measures only taken from the aspects of price setting,ratio of reimbursement and quantity of drug conˉsumption can that be effective;analysis about advantages and disadvantages should be considered in the making of the reˉforming policies about establishing pharmaceutical reference prices and setting up prescription fee and etc.

作者胡善联陈文张崖冰龚向光

机构地区复旦大学公共卫生学院

出处《中国药房》 CAS CSCD 北大核心 2005年第5期355-357,共3页 China Pharmacy

关键词处方药品分类补偿基本药物目录 Prescription drugs Classified reimbursement Essential drug list

分类号 R956 [医药卫生—药学]

引文网络
相关文献

参考文献10

1龚波.基本医疗保险用药管理问题思考及对策分析[A].上海市医疗保险信息中心编.医疗保险研究[M].,2002.1-14.
2Annemans L.Pricing and reimbursement of pharmaceuticals in-Belgium[J] .Pharmacoeconomics, 1997, 11(3):203.
3Pelc Alain, Castan JP .New developments in pricing and drug reimbursement in France[J]. Pharmacoeconomics,1994,6( Suppl. 1) : 28.
4Rigtre H.Recent public policies in the netherlands to control pharmaceutical pricing and reimbursement [J].Pharmacoeconomics, 1994, 6(Suppl. 1) : 15.
5Jonsson B.Pricing and reimbursement of pharmaceuticals in Sweden [J ] . Pharmacoeconomics, 1994,6( Suppl.1):51.
6Towse A.The pricing and reimbursement of pharmaceuticals [ J ] . Pharmacoeconomics , 1994,6( Suppl 1 ) ;36.
7Thomas Ⅲ LG.Pricing, regulation, and competitiveness:lessons for the US from the Japanese pharmaceutical industry [ J ] . Pharmacoeconomics,1994,6(Suppl1) :67.
8Dickson M, Redwood H.Pharmaceutical reference prices ; how do they work in practice [J] . Pharmacoeconomics, 1998, 14(5) :471.
9Federal Ministry of Labour and Social Affairs. Social Security at a Glance [M] .2000.
10Ioannides - Demos LL. Reference - based pricing schemes: effect on pharmaceutical expenditure, resource utilization and health outcomes[J]. Pharmacoeconomics,2002,20(9) : 577.